# Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With Polyps

> **NCT05428410** · — · UNKNOWN · sponsor: **Beijing Tongren Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Chronic Rhino-sinusitis
- IL-4R
- Monoclonal Antibody
- Biomarker

## Interventions

- **OTHER:** IL-4R
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05428410
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-17
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05428410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05428410, "Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With Polyps". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05428410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*